Jefferson J R, Slotte J P, Nemecz G, Pastuszyn A, Scallen T J, Schroeder F
Department of Pharmacology and Cell Biophysics, University of Cincinnati Medical Center, Ohio 45267-0004.
J Biol Chem. 1991 Mar 25;266(9):5486-96.
The potential role of liver fatty acid binding protein (L-FABP) in modulating cellular sterol distribution was examined in mouse L-cell fibroblasts transfected with cDNA encoding L-FABP. L-cells were chosen because they contain only a small amount of endogenous FABP which does not bind [3H]cholesterol, does not enhance intermembrane sterol transfer, and whose content is unaltered by the expression of L-FABP. Transfected L-cells expressed 0.34% of cytosolic protein as L-FABP. Transfection alone with low expression of L-FABP (0.008% of cytosolic protein) had no effect on any of the parameters tested. Three aspects of cellular sterol transfer were examined. First, cellular sterol uptake, monitored by [3H]cholesterol and the fluorescent sterol, delta-5,7,9(11),22-ergostatetraen-3 beta-ol, was increased 21.5 +/- 2.6% (p less than 0.001) in L-cells expressing L-FABP. This increase was not accounted for by increased sterol esterification in the cells expressing L-FABP. Inhibition of both cholesterol transfer and esterification with 3-(decyldimethylsilyl)-N-[2-(4-methylphenyl)-1-phenylethyl]propanamide from Sandoz abolished the L-FABP related enhancement of both [3H]cholesterol uptake and esterification. Second, plasma membrane transbilayer distribution of sterol, determined by fluorescence methods indicated that the majority of sterol was in the inner leaflet of the plasma membrane. In transfected cells expressing L-FABP, twice as much sterol (28 +/- 4%) was present in the exofacial leaflet of the plasma membrane as compared to that of control cells (15 +/- 2%). Third, expression of L-FABP enhanced sterol transfer from the plasma membrane to microsomes in intact cells. Treatment of [3H]cholesterol or [3H]oleate-loaded cells with sphingomyelinase resulted in increased formation of radiolabeled cholesterol ester, consistent with enhanced microsomal esterification of plasma membrane derived cholesterol. Concomitantly, plasma membrane [3H]cholesterol became less accessible to oxidation by cholesterol oxidase. Sphingomyelinase-stimulated cholesterol esterification was 21 +/- 3% greater in transfected cells. Concomitantly, accessibility of plasma membrane [3H]cholesterol to cholesterol oxidase was decreased 18 +/- 3% in cells expressing L-FABP. These differences are consistent with the ability of L-FABP to influence sterol transport and plasma membrane transbilayer sterol distribution in intact cells.
在转染了编码肝脏脂肪酸结合蛋白(L-FABP)的cDNA的小鼠L细胞成纤维细胞中,研究了L-FABP在调节细胞甾醇分布方面的潜在作用。选择L细胞是因为它们仅含有少量内源性FABP,该内源性FABP不结合[3H]胆固醇,不增强膜间甾醇转移,并且其含量不会因L-FABP的表达而改变。转染的L细胞表达的L-FABP占细胞溶质蛋白的0.34%。单独转染且L-FABP低表达(占细胞溶质蛋白的0.008%)对所测试的任何参数均无影响。研究了细胞甾醇转移的三个方面。首先,通过[3H]胆固醇和荧光甾醇δ-5,7,9(11),22-麦角甾四烯-3β-醇监测的细胞甾醇摄取,在表达L-FABP的L细胞中增加了21.5±2.6%(p<0.001)。这种增加不是由表达L-FABP的细胞中甾醇酯化增加所导致的。用山道士公司的3-(癸基二甲基甲硅烷基)-N-[2-(4-甲基苯基)-1-苯乙基]丙酰胺抑制胆固醇转移和酯化,消除了与L-FABP相关的[3H]胆固醇摄取和酯化的增强。其次,通过荧光方法测定的甾醇在质膜的跨双层分布表明,大多数甾醇位于质膜的内膜层。在表达L-FABP的转染细胞中,质膜外表面叶层中的甾醇含量(28±4%)是对照细胞(15±2%)的两倍。第三,L-FABP的表达增强了完整细胞中甾醇从质膜向微粒体的转移。用鞘磷脂酶处理[3H]胆固醇或[3H]油酸负载的细胞,导致放射性标记胆固醇酯的形成增加,这与质膜衍生胆固醇的微粒体酯化增强一致。同时,质膜[3H]胆固醇对胆固醇氧化酶氧化的可及性降低。在转染细胞中,鞘磷脂酶刺激的胆固醇酯化增加了21±3%。同时,在表达L-FABP的细胞中,质膜[3H]胆固醇对胆固醇氧化酶的可及性降低了18±3%。这些差异与L-FABP影响完整细胞中甾醇转运和质膜跨双层甾醇分布的能力一致。